Clinical Trials Logo

Clinical Trial Summary

A closed-loop insulin system, also referred to as the "artificial pancreas" (AP), is made up of an insulin pump, a continuous glucose monitor, and an application communicating between the two to adjust insulin administration based on glucose control. This is meant for the treatment of type 1 diabetes. The McGill Artificial Pancreas (MAP) has been used previously in type 1 diabetes with significant benefits. Though prior studies have shown significant benefit with this system, some challenges still exist. Semaglutide is used in type 2 diabetes and obesity; it is a once-weekly injectable medication that increases levels of a gut hormone called Glucagon-Like Peptide-1, which modifies gastric emptying, suppresses glucagon, and suppresses appetite. Though its use is not approved in type 1 diabetes in North America, it (along with similar drugs) has been used in studies as adjunctive therapy with insulin with benefits on blood sugar control. Similar medications have been used in type 1 diabetes (such as liraglutide and exenatide), but are not as strong in glucose effect even in type 2 diabetes as compared with semaglutide. The purpose of our study is to see if semaglutide administered weekly at the maximum tolerated dose in those with type 1 diabetes will have improved glucose control (as per time in target range from continuous glucose monitoring data) compared to placebo, while using a closed-loop insulin system.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05205928
Study type Interventional
Source McGill University Health Centre/Research Institute of the McGill University Health Centre
Contact Melissa-Rosina Pasqua, MD
Phone (514) 934-1934
Email [email protected]
Status Not yet recruiting
Phase Phase 2/Phase 3
Start date March 1, 2022
Completion date December 30, 2024

See also
  Status Clinical Trial Phase
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT03605329 - Evaluation of the Severity of Cardiovascular Autonomic Neuropathy in Type 1 Diabetic Patients With OSAS N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Active, not recruiting NCT05107544 - Metabolic Effect of High Intensity Interval Training (HIIT) in Adolescents With Type 1 Diabetes N/A
Recruiting NCT04443153 - Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes N/A
Recruiting NCT04521634 - Glycaemic Variability in Acute Stroke
Completed NCT04569994 - A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes Phase 1
Completed NCT04089462 - Effects of Frequency and Duration of Exercise in People With Type 1 Diabetes A Randomized Crossover Study N/A
Completed NCT03143816 - Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study Phase 4
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A
Completed NCT04042207 - Diabeloop for Highly Unstable Type 1 Diabetes N/A
Recruiting NCT04974528 - Afrezza® INHALE-1 Study in Pediatrics Phase 3
Recruiting NCT03988764 - Monogenic Diabetes Misdiagnosed as Type 1
Not yet recruiting NCT04291703 - Low Dose Antithymocyte Globulin (ATG) to Delay or Prevent Progression to Stage 3 T1D Phase 2
Not yet recruiting NCT04304963 - Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS
Recruiting NCT03682640 - Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes Phase 2
Withdrawn NCT03242005 - The PSIQS Study - User Experience With Pro-Set N/A
Recruiting NCT02953249 - Wound Healing After Tooth Extraction in Individuals With Type 1 Diabetes Mellitus N/A
Completed NCT02839174 - Type One Diabetes and Low Carb Study N/A